Riskpilot← Back to searchSign inGet full accessUrsula Junger Aktiebolag
ABActiveOrg 5563433746Lilla Allmänna Gränd 15 AGeneral medical practice activities · NACE 8621Est. 19881 employees
Revenue 2025
SEK 2,5M
-1% vs 2024
EBITDA margin
28.6%
+18% vs 2024
Equity ratio
74.9%
Financial strength
Net profit 2025
SEK 379K
+24% vs 2024
| Revenue | SEK 2,5M | -1% |
| EBITDA | SEK 713K | +18% |
| Net profit | SEK 379K | +24% |
| Total assets | SEK 3,3M | +16% |
| Equity | SEK 2,5M | +18% |
| Employees | 1 | — |
Legal name
Ursula Junger Aktiebolag
Org number
5563433746
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
13 december 1988
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultation och forskning inom medicin, konsultation och utbildning inom kroppsbeteende, handel med inredning, konst antikviteter och mode, inspelning av videofilmer, handel och förvaltning av aktier och andra värdepapper samt fastigheter, ävensom idka därmed förenlig verksamhet.
Address
Lilla Allmänna Gränd 15 A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 745 | 2 349 | 2 473 | 2 508 | 2 495 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 509 | 701 | 538 | 604 | 713 |
| Depreciation & amort. | −77 | −145 | −107 | −99 | −99 |
| EBIT | 432 | 556 | 431 | 505 | 614 |
| Net financials | — | — | — | 3 | 3 |
| Profit before tax | 344 | 448 | 321 | 387 | 481 |
| Tax | −74 | −96 | −68 | −82 | −102 |
| Net profit | 270 | 352 | 253 | 305 | 379 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 578 | 2 183 | 2 460 | 2 829 | 3 286 |
| Equity | 1 173 | 1 525 | 1 778 | 2 082 | 2 462 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 191 | 336 | 250 | 193 | 135 |
| Total debt | 191 | 336 | 250 | 193 | 135 |
EBITDA margin
28.6%
This company
15.8%
Market median
+81% vs market
20212025
Equity ratio
74.9%
This company
38.2%
Market median
+96% vs market
20212025
Return on equity
15.4%
This company
18.4%
Market median
+16% vs market
20212025
Net profit margin
15.2%
This company
8.1%
Market median
+88% vs market
20212025
Asset turnover
0.76×
This company
1.12×
Market median
-32% vs market
20212025
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ursula Junger Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Ludvigh Stensson Nyström | Audit | 0 companies |
| Ursula Birgitta Cecilia Junger | Board of Directors | 0 companies |
| Lars Tomas Hultgren | Deputy Board Member | 0 companies |